Natural Killer Cells Therapeutics Market 2020 Precise Outlook – Affimed, Nkarta Therapeutics, Fortress Biotech, Celgene Corporation, Nantkwest, Fate Therapeutics

The Natural Killer Cells Therapeutics Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The global natural killer cells therapeutics market was valued at $216.219 million in 2018, and is projected to reach $626.769 million by 2025, registering a CAGR of 16.4% from 2018 to 2025. The applications covered in the study include cancer, gastrointestinal diseases and others.

Buy The Report:
https://www.marketinsightsreports.com/report/purchase/11111542614?mode=su?source=openpr&Mode=12

The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the Global Natural Killer Cells Therapeutics Market: Affimed, Nkarta Therapeutics, Fortress Biotech, Celgene Corporation, Nantkwest, Fate Therapeutics, Ziopharm Oncology, Innate Pharma, Glycostem Therapeutics, NKT Therapeutics and others.

The North America natural killer cells therapeutics market share accounted for the highest share 52.4% in 2018 and is expected to continue its dominance throughout the forecast period. This is attributed to significant increase in prevalence of cancer in this region. However, the Asia market is anticipated to grow at the fastest pace, owing to increase in number of patients suffering from cancer, surge in geriatric population, and improvement in healthcare facilities. However, the complexity in regulatory frameworks regarding the approval of immunotherapy is expected to hamper the market growth.

NK cell therapeutics has promising applications in various research institutes. Various ongoing research activities such as NK cells & immunological memory improvements, stress-induced self-recognition, and cell-based therapies are currently in progress. Moreover, certain immuno-monitoring studies are being performed for determining the usage of NK cells. In hospitals, natural killer cell therapies are used to treat cancers using genetic engineering.

Global Natural Killer Cells Therapeutics Market Split by Product Type and Applications:

This report segments the market on the basis of Types are:

NK Cell Therapies
NK Cell Directed Antibodies

On the basis of Application, the market is segmented into:

Research Centers & Institutes
Hospitals
Others

Industry News and Developments:

September 7, 2018: Affimed and Genentech Partner to Develop Immunotherapies Against Cancer Based on Natural Killer Cells
A recent collaboration between Affimed and Genentech, a member of the Roche group, aims to develop immunotherapies — called engager-based immunotherapies — that aim to establish a bridge between a patient’s own immune cells and cancer cells. Affimed will utilize its proprietary Redirected Optimized Cell Killing (ROCK) platform to identify and progress innate immune cell engager-based immunotherapies of interest to Genentech, according to a press release. The ROCK platform is used to generate highly customizable natural killer (NK) cell and T cell-engaging antibodies, which help to boost an immunotherapy’s effectiveness. The antibodies generated from this platform have the potential to stimulate and direct the immune system to target tumor cells. They do this by binding to proteins on both immune cells and cancer cells, bringing them closer together, which improves immune responses.

SOUTH SAN FRANCISCO, Calif., Nov. 18, 2019-- Nkarta Therapeutics, a privately-held biopharmaceutical company developing engineered natural killer (NK) cell therapies to fight cancer, today announced preclinical data were presented in a poster session at the American Association for Cancer Research, Tumor Immunology and Immunotherapy Meeting 2019 in Boston, Massachusetts. The poster, which was presented by Nkarta scientist Luxuan Buren, Ph.D., describes the evaluation of a series of engineered NK cells targeting CD19, a tumor marker found in a variety of B-cell malignancies.

In this research, NK cells were expanded using Nkarta’s proprietary stimulatory cell line, then transduced with a γ-retrovirus encoding different CD19 chimeric antigen receptors, or CARs, and membrane-bound IL-15, Nkarta’s proprietary approach to increase NK cell persistence. In a series of in vitro and in vivo experiments, Nkarta scientists identified a CAR construct containing an OX40 co-stimulatory domain as optimal for further development. This research was used to inform the selection of NKX019, Nkarta’s clinical candidate targeting CD19, with an IND expected in the third quarter of 2020.

Click the link to get a Sample Copy of the Report:
https://www.marketinsightsreports.com/reports/11111542614/global-natural-killer-cells-therapeutics-market-2019-by-company-regions-type-and-application-forecast-to-2024/inquiry?source=openpr&Mode=12

Regional Analysis For Natural Killer Cells Therapeutics Market:

For comprehensive understanding of market dynamics, the global Natural Killer Cells Therapeutics market is analyzed across key geographies namely:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Natural Killer Cells Therapeutics Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger and acquisitions along with trending innovation and business policies are reviewed in the report. The report contains basic, secondary and advanced information pertaining to the Market global status and trend, market size, share, growth, trends analysis, segment and forecasts from 2020–2026.

Following are major Table of Content of Natural Killer Cells Therapeutics Market:

- Global Market Overview, Drivers, Restraints and Opportunities, Segmentation overview
- Global Market competition by top Players
- Analysis by Regions
- Consumption by Regions
- Consumption, By Types, Revenue and Market share by Types
- Consumption, By Applications, Market share (%) and Growth Rate by Applications
- Complete profiling and analysis of Players
- Industrial Chain, Sourcing Strategy and Downstream Buyers
- Marketing Strategy Analysis, Distributors/Traders
- Global Market Effect Factors Analysis
- Global Market Forecast
- Global Market Research Findings and Conclusion, Appendix, methodology and data source

Finally, all aspects of the Global Market are quantitatively as well qualitatively assessed to study the Global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and its future prospects. The report supplies the international economic competition with the assistance of Porter’s Five Forces Analysis and SWOT Analysis.

For More Information On This Report, Please Visit: https://www.marketinsightsreports.com/reports/11111542614/global-natural-killer-cells-therapeutics-market-2019-by-company-regions-type-and-application-forecast-to-2024?source=openpr&Mode=12

We Offer Customization On Report Based On Specific Client Requirement:

– Free country Level analysis for any 5 countries of your choice.
– Free Competitive analysis of any 5 key market players.
– Free 40 analyst hours to cover any other data point.

Browse Related Reports:

Small Interfering RNA (siRNA) Therapeutics Market:
https://www.marketinsightsreports.com/reports/06172094773/covid-19-impact-on-global-small-interfering-rna-sirna-therapeutics-market-size-status-and-forecast-2020-2026?source=openpr&Mode=12

Bipolar Disorder Therapeutics Drugs Market:
https://www.marketinsightsreports.com/reports/06172094232/covid-19-impact-on-global-bipolar-disorder-therapeutics-drugs-market-insights-forecast-to-2026?source=openpr&Mode=12

Psoriasis Therapeutics Market:
https://www.marketinsightsreports.com/reports/06172093717/covid-19-impact-on-global-psoriasis-therapeutics-market-size-status-and-forecast-2020-2026?source=openpr&Mode=12

How we have factored the effect of Covid-19 in our report:
All the reports that we list have been tracking the impact of COVID-19. Both upstream and downstream of the entire supplychain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

CONTACT US:
Irfan Tamboli (Head of Sales) - Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

ABOUT US:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.